HumleRun (@HumleRun) header
HumleRun (@HumleRun) profile picture
Joined January 2022
Had to drop my Radx stake because of reduced borrowing headroom on my Saniona position. $CRBP had a strange day, down almost 10% and fighting the last hour all the way to flat. Saniona got the IND approved for San2465, first patient scheduled before years end.
25
Day 32: Iceland-Luxemburg Ice. lead first half(live17')//38kr 1.95
1
122
✅️ 1310>1346
6
Day 31: Aik-Oskarshamn Aik w overall//79kr 1.42
1
65
✅️ 1277>1310
11
Abstract is public from SNO26 yesterday. Tighter numbers confirmed: 93.5% agreement with MRI overall, 83.9% on previously treated lesions, solid quantitative match, ~86% sensitivity, and very mild side effects in only ~16% of patients. Full data expected later this year. $RADX
2
3
168
Day 30: Kosovo-Israel over 0,5 goals Isr.//70kr 1.50
1
156
Romania-Poland Rom. over 0,5//500kr 1.45
1
22
✅️1052>1277
8
Busy week is continuing. ●SNO26 RADT-51 10:36-10:43am Phase 2b Imaging Study of 18F-RAD101 PET for Detection of Recurrent Brain Metastases Following Radiotherapy Presenting: Harshad R. Kulkarni(PI) $RADX >>>
1
1
434
●Poster: Efficacy, Safety, and Tolerability of CRB-913 in the Phase 1b CANYON-1 Study Sunday, November 15 | 2:30–3:30 PM ET Gaylord National Resort & Convention Center Exhibit Hall BCD, Washington, DC $CRBP >>
1
167
Also, Saniona on Friday announced positive EMA COMP opinion for orphan designation of SAN2668 for rare CHD2-related neurodevelopmental disorder. Sold it shares earlier this week in AstronauTx, extending runway into -29 for own pipeline.
57
Day 29: Netherlands-Greece over 0,5 Greece// 75kr 1.46
1
180
Argentina-Uruguay o 1,5 goals//350kr 1.30
1
151
✅️ 1127>1232
6
Now RBC, Oppenheimer, Mizuho and Wedbush lowered their PT for Corbus. The new avarage PT is 30.75$, all keep the Outperform rating. Down 18,5% at the moment,3.25$, late breaking oral presentation this weekend at ObesityWeek26 coming up. Said I would not buy more but I.. $CRBP
1
186